异常球菌锰离子-肽复合物:甲病毒疫苗开发的新方法
研究利用伽马射线联合合成的锰-十肽-磷酸复合物(MnDpPi)制备委内瑞拉马脑炎病毒(VEEV)和基孔肯雅病毒(CHIKV)灭活疫苗;该复合物在辐照过程中选择性保护蛋白而非核酸,50,000Gy下仍保留表位,灭活病毒在新生小鼠中安全,免疫后VEEV疫苗保护效力大幅提升。
要点
- MnDpPi在伽马辐照中选择性保护病毒蛋白免受氧化损伤,50,000Gy下仍保留表位。
- 辐照后的VEEV和CHIKV完全灭活,在新生小鼠体内安全。
- MnDpPi灭活的VEEV免疫后保护效力大幅提升。
核心结论
- 基于MnDpPi的伽马灭活方法可快速、经济地用于开发针对任何目标病原体的疫苗。
研究设计与样本
- 研究使用伽马射线联合合成的MnDpPi复合物制备VEEV和CHIKV灭活疫苗,并在小鼠中评估免疫原性与保护效力。
主要发现
- VEEV和CHIKV在MnDpPi存在下经伽马射线辐照(50,000Gy)后表位大量保留。
- 辐照病毒完全灭活,在新生小鼠体内安全。
- MnDpPi灭活的VEEV免疫后保护效力大幅提升。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over the last ten years, Chikungunya virus (CHIKV), an Old World alphavirus has caused numerous outbreaks in Asian and European countries and the Americas, making it an emerging pathogen of great global health importance. Venezuelan equine encephalitis virus (VEEV), a New World alphavirus, on the other hand, has been developed as a bioweapon in the past due to its ease of preparation, aerosol dispersion and high lethality in aerosolized form. Currently, there are no FDA approved vaccines against these viruses. In this study, we used a novel approach to develop inactivated vaccines for VEEV and CHIKV by applying gamma-radiation together with a synthetic Mn-decapeptide-phosphate complex (MnDpPi), based on manganous-peptide-orthophosphate antioxidants accumulated in the extremely radiation-resistant bacterium Deinococcus radiodurans. Classical gamma-irradiated vaccine development approaches are limited by immunogenicity-loss due to oxidative damage to the surface proteins at the high doses of radiation required for complete virus-inactivation. However, addition of MnDpPi during irradiation process selectively protects proteins, but not the nucleic acids, from the radiation-induced oxidative damage, as required for safe and efficacious vaccine development. Previously, this approach was used to develop a bacterial vaccine. In the present study, we show that this approach can successfully be applied to protecting mice against viral infections. Irradiation of VEEV and CHIKV in the presence of MnDpPi resulted in substantial epitope preservation even at supra-lethal doses of gamma-rays (50,000Gy). Irradiated viruses were found to be completely inactivated and safe in vivo (neonatal mice). Upon immunization, VEEV inactivated in the presence of MnDpPi resulted in drastically improved protective efficacy. Thus, the MnDpPi-based gamma-inactivation approach described here can readily be applied to developing vaccines against any pathogen of interest in a fast and cost-effective manner.
引用
- Gayen M, Gupta P, Morazzani EM, et al. Deinococcus Mn2+-peptide complex: A novel approach to alphavirus vaccine development. Vaccine. 2017. PMID: 28576570. doi:10.1016/j.vaccine.2017.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。